東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/10/11 | 2,488 | 2,490 | 2,457 | 2,460 | -21 | -0.8% | 95,200 |
2019/10/10 | 2,466 | 2,485 | 2,439 | 2,481 | +13 | +0.5% | 93,200 |
2019/10/09 | 2,438 | 2,472 | 2,423 | 2,468 | +8 | +0.3% | 75,400 |
2019/10/08 | 2,440 | 2,461 | 2,425 | 2,460 | +19 | +0.8% | 93,500 |
2019/10/07 | 2,420 | 2,441 | 2,410 | 2,441 | -4 | -0.2% | 95,800 |
2019/10/04 | 2,450 | 2,450 | 2,415 | 2,445 | -25 | -1% | 113,600 |
2019/10/03 | 2,497 | 2,501 | 2,454 | 2,470 | -100 | -3.9% | 133,600 |
2019/10/02 | 2,500 | 2,582 | 2,479 | 2,570 | +62 | +2.5% | 219,800 |
2019/10/01 | 2,522 | 2,545 | 2,499 | 2,508 | +4 | +0.2% | 128,600 |
2019/09/30 | 2,480 | 2,519 | 2,452 | 2,504 | -6 | -0.2% | 197,400 |
2019/09/27 | 2,552 | 2,558 | 2,473 | 2,510 | -68 | -2.6% | 151,200 |
2019/09/26 | 2,591 | 2,606 | 2,570 | 2,578 | -21 | -0.8% | 159,000 |
2019/09/25 | 2,580 | 2,605 | 2,576 | 2,599 | +37 | +1.4% | 178,700 |
2019/09/24 | 2,546 | 2,571 | 2,528 | 2,562 | +16 | +0.6% | 156,800 |
2019/09/20 | 2,543 | 2,553 | 2,530 | 2,546 | +4 | +0.2% | 147,900 |
2019/09/19 | 2,471 | 2,558 | 2,458 | 2,542 | +55 | +2.2% | 233,900 |
2019/09/18 | 2,474 | 2,500 | 2,462 | 2,487 | +12 | +0.5% | 147,700 |
2019/09/17 | 2,484 | 2,488 | 2,442 | 2,475 | +5 | +0.2% | 117,600 |
2019/09/13 | 2,470 | 2,474 | 2,443 | 2,470 | +17 | +0.7% | 138,900 |
2019/09/12 | 2,450 | 2,465 | 2,431 | 2,453 | +4 | +0.2% | 130,600 |
2019/09/11 | 2,409 | 2,449 | 2,383 | 2,449 | +35 | +1.4% | 178,400 |
2019/09/10 | 2,430 | 2,435 | 2,403 | 2,414 | -19 | -0.8% | 111,300 |
2019/09/09 | 2,393 | 2,435 | 2,385 | 2,433 | +65 | +2.7% | 143,900 |
2019/09/06 | 2,368 | 2,397 | 2,355 | 2,368 | ±0 | ±0% | 148,800 |
2019/09/05 | 2,347 | 2,405 | 2,340 | 2,368 | +40 | +1.7% | 102,800 |
2019/09/04 | 2,340 | 2,340 | 2,317 | 2,328 | -32 | -1.4% | 110,300 |
2019/09/03 | 2,365 | 2,369 | 2,334 | 2,360 | -26 | -1.1% | 116,800 |
2019/09/02 | 2,417 | 2,421 | 2,364 | 2,386 | -49 | -2% | 117,200 |
2019/08/30 | 2,385 | 2,468 | 2,380 | 2,435 | +91 | +3.9% | 326,600 |
2019/08/29 | 2,347 | 2,354 | 2,314 | 2,344 | +18 | +0.8% | 102,800 |
2019/08/28 | 2,320 | 2,332 | 2,302 | 2,326 | -12 | -0.5% | 145,500 |
2019/08/27 | 2,352 | 2,359 | 2,325 | 2,338 | +6 | +0.3% | 122,400 |
2019/08/26 | 2,326 | 2,362 | 2,303 | 2,332 | -60 | -2.5% | 122,700 |
2019/08/23 | 2,407 | 2,410 | 2,365 | 2,392 | +22 | +0.9% | 144,700 |
2019/08/22 | 2,410 | 2,410 | 2,341 | 2,370 | -36 | -1.5% | 167,100 |
2019/08/21 | 2,400 | 2,421 | 2,382 | 2,406 | -27 | -1.1% | 78,600 |
2019/08/20 | 2,430 | 2,448 | 2,408 | 2,433 | +3 | +0.1% | 138,300 |
2019/08/19 | 2,482 | 2,482 | 2,419 | 2,430 | -29 | -1.2% | 93,900 |
2019/08/16 | 2,444 | 2,481 | 2,434 | 2,459 | -11 | -0.4% | 123,200 |
2019/08/15 | 2,419 | 2,476 | 2,381 | 2,470 | +1 | ±0% | 354,500 |
2019/08/14 | 2,465 | 2,499 | 2,443 | 2,469 | +18 | +0.7% | 236,200 |
2019/08/13 | 2,603 | 2,606 | 2,414 | 2,451 | -202 | -7.6% | 465,600 |
2019/08/09 | 2,663 | 2,699 | 2,623 | 2,653 | +20 | +0.8% | 206,200 |
2019/08/08 | 2,630 | 2,643 | 2,594 | 2,633 | -10 | -0.4% | 131,300 |
2019/08/07 | 2,639 | 2,658 | 2,610 | 2,643 | +4 | +0.2% | 179,600 |
2019/08/06 | 2,600 | 2,639 | 2,551 | 2,639 | -21 | -0.8% | 141,900 |
2019/08/05 | 2,686 | 2,699 | 2,625 | 2,660 | -50 | -1.8% | 127,200 |
2019/08/02 | 2,728 | 2,775 | 2,685 | 2,710 | -58 | -2.1% | 139,800 |
2019/08/01 | 2,753 | 2,787 | 2,739 | 2,768 | +24 | +0.9% | 127,100 |
2019/07/31 | 2,755 | 2,786 | 2,736 | 2,744 | -56 | -2% | 176,500 |
1251~
1300
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム